China's first AI-powered cancer vaccine production line set to launch in Beijing
5 hours ago
- #biotechnology
- #cancer vaccine
- #AI healthcare
- China has launched its first AI-assisted personalized tumor vaccine production line in Beijing.
- The facility will produce LK101, a personalized cancer vaccine that analyzes tumor DNA to target specific mutations.
- AI technology enables rapid processing, completing the procedure in just one day.
- This project reflects a global trend in pharmaceuticals towards using AI in drug discovery and clinical trials.
- The global AI healthcare market is projected to exceed US$1 trillion by 2035.